Auf dieser Seite
ODYS Odysight.ai Inc. - Common Stock
NASDAQ · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 13, 2026
$2,81
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$2,5152-Wochen-Tief
$11,3052-Wochen-Hoch
Marktkapitalisierung (MRQ)
$47M
P/E (TTM)
-2.5
EPS (TTM)
$-1.11
Umsatz (TTM)
$1M
Ihre Abzeichen
52W-Spanne
$3–$11
Analystenbewertung
BUY
Kursziel
$7
P/E
-2.5
ROE
-72.8%
Nettogewinnmarge
-1669.7%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
ODYS Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$2.81
Marktkapitalisierung (MRQ)
$47M
P/E (TTM)
-2.5
EPS (TTM)
$-1.11
Umsatz (TTM)
$1M
ROE (TTM)
-72.8%
52W-Spanne
$3–$11
ODYS Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 11. August 2021 | 1-for-9 | Umgekehrt |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$3M2018-12-31 → 2025-12-31
EPS$-1.072022-12-31 → 2025-12-31
Freier Cashflow$-14M2019-12-31 → 2025-12-31
Nettogewinnmarge-1669.7%2019-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | ODYS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -2.55-Jahres-Durchschnitt ≈-4.4 | ≈-4.4 | · | · | |
| P/S (TTM) | 43.35-Jahres-Durchschnitt ≈61.0 | ≈61.0 | 2.8 | Überbewertet | |
| K/B (MRQ) | 2.75-Jahres-Durchschnitt ≈3.4 | ≈3.4 | 3.1 | Überbewertet | |
| Kurs / FCF (TTM) | -2.95-Jahres-Durchschnitt ≈-7.7 | ≈-7.7 | · | · | |
| Kurs / Cashflow (TTM) | -2.95-Jahres-Durchschnitt ≈-7.9 | ≈-7.9 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 1.85-Jahres-Durchschnitt ≈3.1 | ≈3.1 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | ODYS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Bruttogewinnmarge (TTM) | 34.9%5-Jahres-Durchschnitt ≈-68.4% | ≈-68.4% | 39.9% | Im Einklang | |
| Betriebsgewinnmarge (TTM) | -1743.7%5-Jahres-Durchschnitt ≈-1172.7% | ≈-1172.7% | -82.9% | Schwach | |
| EBITDA Margin (EBITDA-Marge) | -601.5%5-Jahres-Durchschnitt ≈-1172.7% | ≈-1172.7% | -82.9% | Schwach | |
| Pretax Margin (Vorgewinnmarge) | 565.0%5-Jahres-Durchschnitt ≈-869.5% | ≈-869.5% | -33.8% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | -1669.7%5-Jahres-Durchschnitt ≈-1152.0% | ≈-1152.0% | -89.4% | Schwach | |
| ROA (TTM) | -62.8%5-Jahres-Durchschnitt ≈-55.8% | ≈-55.8% | -30.2% | Schwach | |
| ROE (TTM) | -72.8%5-Jahres-Durchschnitt ≈-59.4% | ≈-59.4% | -24.5% | Schwach | |
| ROIC | -71.3% | · | -23.7% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | ODYS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 5.85-Jahres-Durchschnitt ≈9.1 | ≈9.1 | 5.2 | Im Einklang | |
| Quick Ratio | 8.75-Jahres-Durchschnitt ≈6.3 | ≈6.3 | 3.9 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | ODYS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -23.9%5-Jahres-Durchschnitt ≈82.7% | ≈82.7% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 65.5%5-Jahres-Durchschnitt ≈88.7% | ≈88.7% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 43.8% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | ODYS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.15-Jahres-Durchschnitt ≈0.1 | ≈0.1 | 0.5 | Schwach | |
| Inventory Turnover (Lagerumschlag) | 16.95-Jahres-Durchschnitt ≈8.6 | ≈8.6 | 1.4 | Spitzenklasse | |
| Receivables Turnover (Forderungsumschlag) | 3.45-Jahres-Durchschnitt ≈14.2 | ≈14.2 | 5.7 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$58.0K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-83.1%
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 31. März 2026 | Mai 14, 2026 | $-0.32 | $-0.30 | -8.2% |
| 30. Juni 2025 | $-0.25 | $-0.12 | -104.2% | |
| 31. März 2025 | $-0.29 | $-0.12 | -136.9% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3M | $4M | $3M | $665.0K | $387.0K | $491.0K | $309.0K | $391.0K | |
| Cost of Revenue | $2M | $3M | $3M | $2M | $1M | $994.0K | $542.0K | $221.0K | |
| Gross Profit | $871.0K | $1M | $509.0K | $-966.0K | $-721.0K | $-503.0K | $-233.0K | $170.0K | |
| R&D Expense | $10M | $7M | $6M | $4M | $2M | $725.0K | $274.0K | $183.0K | |
| SG&A Expense | $7M | $6M | $4M | $4M | $5M | $3M | $1M | $240.0K | |
| Operating Income | $-18M | $-13M | $-11M | $-9M | $-9M | $-5M | $-2M | $-523.0K | |
| Pretax Income | $17M | $12M | $-9M | $-9M | $-9M | $-5M | $-2M | $-523.0K | |
| Income Tax | $0 | · | · | · | $229.0K | $2.0K | $2.0K | $1.0K | |
| Net Income | $-17M | $-12M | $-9M | $-9M | $-9M | $-5M | $-2M | $-524.0K | |
| EPS (Basic) | $-1.07 | $-1.03 | $-0.98 | $-1.33 | $-1.44 | · | · | · | |
| EPS (Diluted) | $-1.07 | $-1.03 | $-0.98 | $-1.33 | · | · | · | · | |
| Shares (Basic) | 15,900 | 11,445 | 9,668,000 | 7,122 | 6,240,000 | · | · | · | |
| Shares (Diluted) | 15,900 | 11,445 | 9,668,000 | 7,122 | · | · | · | · | |
| EBITDA | $-18M | $-13M | · | $-9M | $-9M | $-5M | $-2M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $26M | $18M | $9M | $10M | $9M | $3M | $3M | · | |
| Receivables | $278.0K | $2M | $1M | $60.0K | $8.0K | $17.0K | $22.0K | $90.0K | |
| Inventory | $50.0K | $203.0K | $504.0K | $630.0K | $167.0K | $244.0K | $900.0K | $81.0K | |
| Other Current Assets | $549.0K | $588.0K | $432.0K | $281.0K | $443.0K | $348.0K | $78.0K | $62.0K | |
| Current Assets | $28M | $21M | $19M | $14M | $20M | $4M | $4M | $233.0K | |
| PP&E (Net) | $346.0K | $407.0K | $477.0K | $648.0K | $781.0K | $269.0K | $59.0K | $13.0K | |
| PP&E (Gross) | $1M | $1M | $1M | $1M | $1M | $408.0K | $132.0K | · | |
| Accum. Depreciation | $797.0K | $680.0K | $557.0K | $504.0K | $253.0K | $139.0K | $73.0K | $273.0K | |
| Other Non-current Assets | $96.0K | $96.0K | $96.0K | · | · | · | · | · | |
| Total Assets | $29M | $24M | $23M | $17M | $24M | $6M | $5M | $516.0K | |
| Accounts Payable | $480.0K | $442.0K | $287.0K | $297.0K | $103.0K | $79.0K | $35.0K | $19.0K | |
| Accrued Liabilities | $209.0K | $261.0K | $132.0K | · | · | · | · | · | |
| Current Liabilities | $3M | $3M | $2M | $3M | $1M | $772.0K | $2M | $182.0K | |
| Capital Leases | $259.0K | $508.0K | $856.0K | $64.0K | $203.0K | $47.0K | $29.0K | · | |
| Other Non-current Liabilities | · | · | $28.0K | · | · | · | · | · | |
| Total Liabilities | $4M | $5M | $5M | $5M | $4M | $2M | $2M | $634.0K | |
| Common Stock | $17.0K | $13.0K | $10.0K | $7.0K | $7.0K | $4.0K | $27.0K | $16.0K | |
| Paid-in Capital | · | · | · | · | · | · | $4M | $-16.0K | |
| Retained Earnings | $-63M | $-46M | $-34M | $-25M | $-15M | $-6M | $-2M | · | |
| Stockholders' Equity | $25M | $18M | $18M | $12M | $20M | $4M | $3M | $-118.0K | |
| Liabilities + Equity | $29M | $24M | $23M | $17M | $24M | $6M | $5M | $516.0K | |
| Shares Outstanding | 16,357,327 | 12,612,517 | 10,443,768 | 7,121,737 | 7,121,737 | 4,084,122 | 26,884,921 | 16,130,952 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $2M | $2M | $2M | $2M | $1M | $27.0K | $25.0K | |
| Operating Cash Flow | $-14M | $-8M | $-10M | $-6M | $-6M | $-4M | $-2M | $-454.0K | |
| CapEx | $56.0K | $53.0K | $113.0K | $118.0K | $595.0K | $276.0K | $52.0K | · | |
| Investing Cash Flow | $254.0K | $8M | $-5M | $8M | $-12M | $-276.0K | $-55.0K | $4.0K | |
| Stock Issued | · | · | · | · | · | $3.30B | $3M | · | |
| Net Stock Activity | · | · | · | · | · | $3.30B | $3M | · | |
| Financing Cash Flow | $21M | $10M | $14M | · | $23M | $5M | $5M | $450.0K | |
| Net Change in Cash | · | · | · | · | · | $43.0K | $3M | · | |
| Free Cash Flow | $-14M | $-8M | · | $-6M | $-6M | $-4M | $-2M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 28.9% | 29.2% | · | -145.3% | -186.3% | -102.4% | -75.4% | · | |
| Operating Margin | -601.5% | -315.5% | · | -1419.4% | -2354.5% | -958.5% | -584.8% | · | |
| Net Margin | -565.0% | -296.9% | · | -1423.8% | -2322.2% | -950.5% | -591.9% | · | |
| Pretax Margin | 565.0% | -296.9% | · | -1423.8% | -2322.2% | -950.1% | 591.3% | · | |
| EBITDA Margin | -601.5% | -315.5% | · | -1419.4% | -2354.5% | -958.5% | -584.8% | · | |
| ROA | -64.7% | -50.6% | · | -46.8% | -61.1% | -81.0% | -76.5% | · | |
| ROE | -58.7% | -60.1% | · | -74.2% | -44.7% | -128.3% | -132.6% | · | |
| ROIC | -71.3% | · | · | · | · | -118.8% | -71.7% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.2 | 6.3 | · | 5.5 | 15.4 | 5.2 | 2.3 | · | |
| Quick Ratio | 8.7 | 6.0 | · | 4.0 | 6.6 | 4.4 | 1.7 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.2 | · | 0.0 | 0.0 | 0.1 | 0.1 | · | |
| Inventory Turnover | 16.9 | 7.9 | · | 4.1 | 5.4 | 1.2 | 1.1 | · | |
| Receivables Turnover | 3.4 | 2.8 | · | 19.6 | 31.0 | 57.8 | 5.5 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.55 | $1.45 | · | $1.65 | $2.75 | $0.11 | $0.09 | · | |
| Revenue / Share | $189.62 | $0.35 | · | · | · | · | · | · | |
| Cash Flow / Share | $-861.82 | $-0.72 | · | · | · | · | · | · | |
| Cash / Share | $1.57 | $1.44 | · | $1.42 | $1.20 | $0.09 | $0.12 | · | |
| EPS (TTM) | $-1.07 | $-1.03 | $-0.98 | $-1.33 | · | · | · | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -23.9% | 30.7% | 356.1% | 71.8% | -21.2% | · | · | · | |
| Revenue CAGR 3Y | 65.5% | 117.2% | 83.5% | · | · | · | · | · | |
| Revenue CAGR 5Y | 43.8% | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3M | $4M | $3M | $665.0K | $387.0K | $491.0K | $309.0K | · | |
| Net Income TTM | $-17M | $-12M | $-9M | $-9M | $-9M | $-5M | $-2M | · | |
| Market Cap | $54M | $101M | · | $36M | $57M | · | · | · | |
| P/E | -3.1 | -7.8 | -3.1 | -3.8 | · | · | · | · | |
| P/S | 17.9 | 25.5 | · | 53.5 | 147.2 | · | · | · | |
| P/B | 2.1 | 5.5 | · | 3.0 | 2.9 | · | · | · | |
| P / Tangible Book | 2.1 | 5.5 | 1.8 | 3.0 | 2.9 | · | · | · | |
| P / Cash Flow | -3.9 | -12.3 | · | -5.8 | -9.7 | · | · | · | |
| P / FCF | -3.9 | -12.2 | · | -5.7 | -8.8 | · | · | · | |
| Earnings Yield | -32.4% | -12.9% | -32.1% | -26.6% | · | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $420.0K | $82.0K | $439.0K | $149.0K | $362.0K | $2M | $1M | $1M | $1M | $187.0K | $2M | $110.0K | $674.0K | $303.0K | $159.0K | $134.0K | |
| Cost of Revenue | $261.0K | $61.0K | $262.0K | $126.0K | $229.0K | $2M | $843.0K | $887.0K | $667.0K | $410.0K | $876.0K | $321.0K | $777.0K | $550.0K | $352.0K | $430.0K | |
| Gross Profit | $159.0K | $21.0K | $177.0K | $23.0K | $133.0K | $538.0K | $461.0K | $405.0K | $514.0K | $-223.0K | $1M | $-211.0K | $-103.0K | $-247.0K | $-193.0K | $-296.0K | |
| R&D Expense | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | |
| SG&A Expense | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $958.0K | $315.0K | $810.0K | |
| Operating Income | $-5M | $-5M | $-4M | $-5M | $-4M | $-5M | $-4M | $-3M | $-2M | $-3M | $-2M | $-3M | $-3M | $-3M | $-2M | $-2M | |
| Net Income | $-4M | $-5M | $-4M | $-4M | $-4M | $-4M | $-4M | $-3M | $-2M | $-3M | $-1M | $-3M | $-3M | $-3M | $-2M | $-2M | |
| EPS (Basic) | $-0.26 | $-0.32 | $-0.26 | $-0.27 | $-0.25 | $-0.29 | $-0.29 | $-0.23 | $-0.21 | $-0.30 | $-0.09 | $-0.24 | $-0.28 | $-0.37 | $-0.23 | $-0.32 | |
| EPS (Diluted) | $-0.26 | $-0.32 | $-0.26 | $-0.27 | $-0.25 | $-0.29 | $-0.29 | $-0.23 | $-0.21 | $-0.30 | $-0.09 | $-0.24 | $-0.28 | $-0.37 | $-0.23 | $-0.32 | |
| Shares (Basic) | 16,793,000 | 16,387,000 | · | 16,331,000 | 16,316,000 | 14,575,000 | · | 12,255,000 | 10,449,000 | 10,445,000 | · | 10,439,000 | 10,435,000 | 7,276 | · | 7,122,000 | |
| Shares (Diluted) | 16,793,000 | 16,387,000 | · | 16,331,000 | 16,316,000 | 14,575,000 | · | 12,255,000 | 10,449,000 | 10,445,000 | · | 10,439,000 | 10,435,000 | 7,276 | · | 7,122,000 | |
| EBITDA | $-5M | $-5M | · | $-5M | $-4M | $-5M | · | $-3M | $-2M | $-3M | · | $-3M | $-3M | $-3M | · | $-2M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $17M | $22M | $26M | $29M | $33M | $37M | $18M | $21M | $13M | $7M | $9M | $16M | $3M | $10M | $10M | $3M | |
| Receivables | $677.0K | $104.0K | $278.0K | $354.0K | $509.0K | $192.0K | $2M | $912.0K | $758.0K | $123.0K | $1M | · | $158.0K | $61.0K | $60.0K | $15.0K | |
| Inventory | $244.0K | $313.0K | $50.0K | · | · | · | $203.0K | $328.0K | $439.0K | $604.0K | $504.0K | $782.0K | $724.0K | $693.0K | $630.0K | $652.0K | |
| Other Current Assets | $754.0K | $453.0K | $1M | $1M | $1M | $692.0K | $588.0K | $634.0K | $657.0K | $562.0K | $432.0K | $573.0K | $668.0K | $564.0K | $281.0K | $272.0K | |
| Current Assets | $20M | $23M | $28M | $31M | $35M | $38M | $21M | $23M | $15M | $17M | $19M | $21M | $24M | $26M | $14M | $16M | |
| PP&E (Net) | $249.0K | $325.0K | $346.0K | $360.0K | $379.0K | $407.0K | $407.0K | $423.0K | $443.0K | $466.0K | $477.0K | $503.0K | $513.0K | $508.0K | $648.0K | $708.0K | |
| PP&E (Gross) | · | · | $1M | · | · | · | $1M | · | · | · | $1M | · | · | · | $1M | · | |
| Accum. Depreciation | · | · | $797.0K | · | · | · | $680.0K | · | · | · | $557.0K | · | · | · | $504.0K | · | |
| Other Non-current Assets | $96.0K | $96.0K | $96.0K | $96.0K | $96.0K | $96.0K | $96.0K | $96.0K | $96.0K | $96.0K | $96.0K | · | · | · | · | · | |
| Total Assets | $21M | $25M | $29M | $33M | $37M | $40M | $24M | $26M | $19M | $21M | $23M | $25M | $26M | $28M | $17M | $19M | |
| Accounts Payable | $448.0K | $446.0K | $480.0K | $357.0K | $554.0K | $486.0K | $442.0K | $301.0K | $292.0K | $399.0K | $287.0K | $293.0K | $774.0K | $365.0K | $297.0K | $366.0K | |
| Accrued Liabilities | $176.0K | $212.0K | $209.0K | $453.0K | $326.0K | $378.0K | $261.0K | $209.0K | · | · | $132.0K | · | · | · | · | · | |
| Current Liabilities | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | |
| Capital Leases | $246.0K | $195.0K | $259.0K | $309.0K | $381.0K | $406.0K | $508.0K | $601.0K | $669.0K | $779.0K | $856.0K | $957.0K | $339.0K | $94.0K | $64.0K | $85.0K | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | $28.0K | $28.0K | $28.0K | · | · | · | |
| Total Liabilities | $4M | $3M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $6M | $6M | $5M | $5M | $5M | |
| Common Stock | $17.0K | $17.0K | $17.0K | $17.0K | $17.0K | $17.0K | $13.0K | $13.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $7.0K | $7.0K | |
| Retained Earnings | $-73M | $-68M | $-63M | $-59M | $-54M | $-50M | $-46M | $-42M | $-40M | $-37M | $-34M | $-33M | $-30M | $-27M | $-25M | $-23M | |
| Stockholders' Equity | $17M | $21M | $25M | $29M | $33M | $36M | $18M | $21M | $13M | $15M | $18M | $19M | $21M | $23M | $12M | $14M | |
| Liabilities + Equity | $21M | $25M | $29M | $33M | $37M | $40M | $24M | $26M | $19M | $21M | $23M | $25M | $26M | $28M | $17M | $19M | |
| Shares Outstanding | 16,806,905 | 16,773,407 | 16,357,327 | 16,334,158 | 16,326,656 | 16,307,321 | 12,612,517 | 12,607,516 | 10,457,933 | 10,446,685 | 10,443,768 | 10,440,850 | 10,436,684 | 10,432,518 | 7,121,737 | 7,121,737 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $452.0K | $886.0K | $513.0K | $914.0K | $845.0K | $806.0K | $886.0K | $537.0K | $463.0K | $500.0K | $608.0K | $371.0K | $337.0K | $348.0K | $-278.0K | $459.0K | |
| Operating Cash Flow | $-4M | $-4M | $-4M | $-3M | $-4M | $-2M | $-3M | $-2M | $-2M | $-1M | $-3M | $-2M | $-3M | $-2M | $-2M | $-2M | |
| CapEx | $28.0K | $6.0K | $15.0K | $11.0K | $3.0K | $27.0K | $15.0K | $8.0K | $8.0K | $22.0K | $19.0K | $37.0K | $42.0K | $15.0K | $31.0K | $45.0K | |
| Investing Cash Flow | $-337.0K | $-6.0K | $-15.0K | $-11.0K | $-3.0K | $283.0K | $-325.0K | $-8.0K | $8M | $-22.0K | $-5M | $15M | $-4M | $-12M | $9M | $-3M | |
| Stock Issued | · | · | · | · | $-35.0K | $21M | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | $-35.0K | $21M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $101.0K | $32.0K | $82.0K | $1.0K | $34.0K | $21M | $-32.0K | $10M | · | · | $-26.0K | $-78.0K | $-64.0K | $14M | · | · | |
| Free Cash Flow | $-4M | $-4M | · | $-3M | $-4M | $-2M | · | $-2M | $-2M | $-1M | · | $-2M | $-3M | $-2M | · | $-2M |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 37.9% | 25.6% | · | 15.4% | 36.7% | 26.1% | · | 31.4% | 43.5% | -119.2% | · | -191.8% | -15.3% | -81.5% | · | · | |
| Operating Margin | -1078.8% | -6509.8% | · | -3159.1% | -1226.0% | -220.8% | · | -233.4% | -200.2% | -1798.9% | · | -2610.9% | -462.8% | -917.2% | · | · | |
| Net Margin | -1029.5% | -6318.3% | · | -2963.8% | -1125.7% | -206.5% | · | -221.9% | -184.8% | -1690.9% | · | -2310.9% | -426.7% | -886.5% | · | · | |
| EBITDA Margin | -1078.8% | -6509.8% | · | -3159.1% | -1226.0% | -220.8% | · | -233.4% | -200.2% | -1798.9% | · | -2610.9% | -462.8% | -917.2% | · | · | |
| ROA | -14.9% | -16.1% | · | -14.9% | -14.8% | -14.1% | · | -11.3% | -9.7% | -12.9% | · | -11.7% | -12.1% | -10.4% | · | -10.5% | |
| ROE | -17.3% | -18.2% | · | -17.6% | -17.7% | -16.8% | · | -14.5% | -12.8% | -16.4% | · | -15.8% | -15.8% | -13.1% | · | -13.1% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.8 | 7.8 | · | 9.8 | 10.6 | 11.1 | · | 7.9 | 5.8 | 6.4 | · | 7.3 | 7.9 | 9.9 | · | 6.3 | |
| Quick Ratio | 5.2 | 7.3 | · | 9.3 | 10.1 | 10.8 | · | 7.5 | 5.3 | 2.8 | · | 5.6 | 1.2 | 3.7 | · | 1.0 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 | · | 0.1 | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | |
| Inventory Turnover | 2.1 | 0.4 | · | · | · | · | · | 1.6 | 1.1 | 0.6 | · | 0.4 | 1.2 | 1.2 | · | 1.1 | |
| Receivables Turnover | 0.7 | 0.6 | · | 0.2 | 0.6 | 13.1 | · | 2.8 | 2.6 | 2.0 | · | · | 5.2 | 8.1 | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.03 | $1.26 | · | $1.78 | $2.00 | $2.19 | · | $1.66 | $1.28 | $1.45 | · | $1.78 | $1.99 | $2.24 | · | $1.93 | |
| Revenue / Share | $0.03 | $0.01 | · | $0.01 | $0.02 | $0.14 | · | $0.11 | $0.11 | $17.90 | · | $0.01 | $0.06 | · | · | · | |
| Cash Flow / Share | $-0.27 | $-0.26 | · | $-0.21 | $-0.26 | $-0.15 | · | $-0.18 | $-0.20 | $-117.76 | · | $-0.22 | $-0.25 | · | · | · | |
| Cash / Share | $1.02 | $1.30 | · | $1.80 | $2.02 | $2.26 | · | $1.66 | $1.27 | $0.70 | · | $1.53 | $0.32 | $0.92 | · | $0.36 | |
| EPS (TTM) | $-1.11 | $-1.10 | · | $-1.10 | $-1.06 | $-1.02 | · | $-0.83 | $-0.84 | $-0.91 | · | $-1.12 | $-1.20 | $-1.31 | · | · |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $1M | · | $4M | $5M | $6M | · | $5M | $3M | $3M | · | $1M | $1M | $966.0K | · | · | |
| Net Income TTM | $-18M | $-18M | · | $-16M | $-15M | $-13M | · | $-10M | $-9M | $-10M | · | $-10M | $-9M | $-9M | · | · | |
| Market Cap | $70M | $117M | · | $74M | $83M | $114M | · | $76M | $63M | $78M | · | $33M | $33M | $34M | · | $43M | |
| P/E | -3.7 | -6.3 | · | -4.1 | -4.8 | -6.9 | · | -7.2 | -7.1 | -8.2 | · | -2.9 | -2.6 | -2.5 | · | · | |
| P/S | 64.1 | 113.0 | · | 18.9 | 16.6 | 19.6 | · | 16.4 | 18.3 | 26.9 | · | 26.8 | 25.9 | 35.1 | · | · | |
| P/B | 4.0 | 5.5 | · | 2.5 | 2.6 | 3.2 | · | 3.6 | 4.7 | 5.2 | · | 1.8 | 1.6 | 1.5 | · | 3.1 | |
| P / Tangible Book | 4.0 | 5.5 | · | 2.5 | 2.6 | 3.2 | · | 3.6 | 4.7 | 5.2 | · | 1.8 | 1.6 | 1.5 | · | 3.1 | |
| P / Cash Flow | -15.7 | -27.4 | · | -21.5 | -20.0 | -51.3 | · | -34.4 | -30.0 | -63.7 | · | -14.8 | -12.6 | -13.7 | · | -25.0 | |
| Earnings Yield | -26.7% | -15.8% | · | -24.4% | -20.8% | -14.5% | · | -13.8% | -14.0% | -12.1% | · | -35.0% | -38.1% | -40.3% | · | · |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $3M | $4M | $3M | $665.0K | $387.0K |
| Bruttogewinnmarge % | 28.9% | 29.2% | · | -145.3% | -186.3% |
| Betriebsgewinnmarge % | -601.5% | -315.5% | · | -1419.4% | -2354.5% |
| Nettoergebnis | $-17M | $-12M | $-9M | $-9M | $-9M |
| Verwässerte EPS | $-1.07 | $-1.03 | $-0.98 | $-1.33 | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 9.2 | 6.3 | · | 5.5 | 15.4 |
| Quick Ratio | 8.7 | 6.0 | · | 4.0 | 6.6 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-14M | $-8M | · | $-6M | $-6M |
Institutionelle Eigentümer (13F) 16 Einreicher · $16.1M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
16
Gehaltener Wert
$16.1M
Neue Positionen
6
Geschlossene Positionen
1
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 6 (+5 vs. Vorquartal) | 1 (-1 vs. Vorquartal) | 3 (+1 vs. Vorquartal) | 3 (+1 vs. Vorquartal) | -456K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Phoenix Financial Ltd. | $7.715.459 | 1.854.678 | 47,82% | Aktien |
| Y.D. More Investments Ltd | $2.697.924 | 648.776 | 16,72% | Aktien |
| Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD | $2.617.648 | 624.737 | 16,22% | Aktien |
| Yelin Lapidot Holdings Management Ltd. | $855.417 | 205.629 | 5,30% | Aktien |
| Noked Israel Ltd | $836.044 | 200.972 | 5,18% | Aktien |
| Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD | $821.240 | 196.000 | 5,09% | Aktien |
| BlackRock, Inc. | $153.778 | 36.966 | 0,95% | Aktien |
| MEITAV INVESTMENT HOUSE LTD | $130.504 | 31.296 | 0,81% | Aktien |
| CITADEL ADVISORS LLC | $123.710 | 29.738 | 0,77% | Aktien |
| JANE STREET GROUP, LLC | $86.203 | 20.546 | 0,53% | Aktien |
| XTX Topco Ltd | $46.355 | 11.143 | 0,29% | Aktien |
| UBS Group AG | $39.266 | 9.439 | 0,24% | Aktien |
| OSAIC HOLDINGS, INC. | $7.488 | 1.800 | 0,05% | Aktien |
| Tower Research Capital LLC (TRC) | $2.575 | 619 | 0,02% | Aktien |
| JPMORGAN CHASE & CO | $913 | 219 | 0,01% | Aktien |
| Harel Insurance Investments & Financial Services Ltd. | $38 | 9.000 | 0,00% | Aktien |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| M. Arkin (1999) Ltd., Moshe Arkin | 9. September 2026 | 33,34% | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 8 Insider · 3 Führungskräfte · 4 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Yehu Ofer | Chief Executive Officer | 10. März 2025 A | · | 0 | 0 | $0 |
| Ronen Tanami | Chief Operating Officer | 19. Mai 2026 A | · | 0 | 0 | $0 |
| Eilam Sagi | Chief Business Officer | 19. Februar 2026 A | · | 0 | 0 | $0 |
| Zeev Vurembrand | Direktor | 20. August 2026 P | 46.250 | 1 | 0 | $100.000 |
| Benad Goldwasser | Direktor | 20. August 2026 P | 121.875 | 1 | 0 | $150.000 |
| Moshe Arkin | Direktor | 20. August 2026 P | 4.084.143 | 1 | 0 | $3.600.000 |
| Jackson Schneider | Direktor | 17. September 2025 A | · | 0 | 0 | $0 |
| Y.D. More Investments Ltd | 10%-Eigentümer | 6. Januar 2026 S | 0 | 0 | 17 | $-2.526.507 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 3 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
ODYS Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 8 Analysten
KAUF
Median-Ziel
$6.58
+134,0%
2 25,0%
Starker Kauf
5 62,5%
Kauf
1 12,5%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
2 Analysten · 2026-09-29Mittelwert-Ziel $6.58 +134,0%
← Unter allen Zielen
Aktueller Preis $2.81
Tief$6.00
Mittelwert$6.58
Hoch$7.15
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ODYS | $54M | -3.1 | -23.9% | -565.0% | -58.7% | 28.9% |
| STEX | $151M | -0.3 | 122.2% | 29068.8% | -703.0% | · |
| GUTS | $337M | -1.2 | -22.5% | · | 3220.3% | · |
| DXR | · | · | · | · | · | · |
| MDAI | · | · | · | · | · | · |
| COCH | · | · | · | · | · | · |
| POCI | $56M | -11.9 | 65.2% | -11.5% | -24.5% | 17.2% |
| SRTS | $66M | -8.5 | -34.3% | -28.1% | -15.4% | 43.2% |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 13, 2026